Transcriptome analysis revealed that lower levels of DDX3X promote the expression of genes in the SPINK1-metallothionein pathway, resulting in tumor growth, metastasis, and poorer prognosis in RCC patients [105]. Here, DDX3X is linked to renal cell carcinoma.